Loading...

SUN-178 A Not So "Sweet" DKA: A Case of Euglycemic Diabetic Ketoacidosis Caused by Dapagliflozin/Liraglutide Combination

Background: Combined use of Glucagon-like peptide-1 receptor agonists (GLP-1RA) & sodium-glucose cotransporter 2 inhibitors (SGLT2i) may provide particular advantages for treating type 2 diabetes mellitus (DM2). Both promote weight loss and have favorable effects on cardiovascular outcomes while...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Endocr Soc
Main Authors: Sideri Gugger, Aristea, Stamatiades, George, Viana, Gracia, Elahee, Mehreen, Majumdar, Sachin
Format: Artigo
Sprog:Inglês
Udgivet: Endocrine Society 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553086/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-178
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!